Delivery Order SPE2DB22D3501-SPE2DB25FXH23
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 70 mg tablets (60-count units) under a firm fixed-price contract valued at $4,583.27, with an ultimate completion date of September 29, 2025. This non-set-aside delivery order represents a competitive award to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dasatinib 50 mg tablets (60-count units) with a ceiling value of $26,228.57. This firm fixed-price delivery order is set to conclude by September 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $25,721.56 delivery order to AmerisourceBergen Drug Corp for Dasatinib 80 mg tablets in a 30-count supply on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place...
- The Defense Logistics Agency awarded a $6,641.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dasatinib 100 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This non-set-aside contract represents a routine pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare...
- The Defense Logistics Agency's Medical Supply Chain awarded a $43,070.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Dasatinib 100 mg on September 15, 2025. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania and an ultimate completion date of September 16, 2025. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 60 tablets of the medication Dasatinib 50 mg. The contract has a ceiling value of $40,984.03 and a completion date of July 2, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there is no information provided about any subcontractors. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order by the Defense Logistics Agency valued at $15,067.36 for the supply of Sprycel 100 mg tablets in quantities of 30. The contract is classified as firm fixed price and carries an ultimate completion date of August 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,854.78 on September 15, 2025, for the supply of Sprycel 100 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is non-set-aside and is scheduled for completion by September 16, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency for the supply of Attruby 356 mg tablets (28-count packages) with a firm fixed price structure. The award, made on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Sprycel 50 mg tablets (60-count units) at a ceiling value of $11,156.18. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...